insights_auto
Why is ALNOV down 3,30%?
Dive Deeperchevron_right
ALNOV:EPA
Novacyt SA
0,43 €
arrow_downward
-3,30%(-0,014) 1D
20-ноя., 17:35:10 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
0,43 €
High
0,44 €
Low
0,42 €
Mkt. cap
30,76 млн
Avg. vol.
128,00 миң
Volume
64,11 миң
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,37 €
Shares outstanding
72,59 млн
No. of employees
228
Open
0,43 €
High
0,44 €
Low
0,42 €
Mkt. cap
30,76 млн
Avg. vol.
128,00 миң
Volume
64,11 миң
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,37 €
Shares outstanding
72,59 млн
No. of employees
228
News stories
From web sources and news partners
WHEC.com
·
25 мүнөт мурун
US stocks tumble, and the S&P 500 drops as the sell-off for AI stocks accelerates
TradingView
·
41 мүнөт мурун
S&P 500 enters correction territory and these 20 names are fueling the leg lower
Investor's Business Daily
·
35 мүнөт мурун
This VIX Signal Is Bullish For The S&P 500.
investingLive
·
1 саат мурун
NASDAQ composite is now down on the year
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEODavid Allmond
Employees228
Founded2006-ж., 3-июл.
Headquarters-
SectorHealth Care
Industry-
Websitenovacyt.com